Prenatal testing for infectious disease

Clinics in Laboratory Medicine

Volumn 23, Issue 2, 2003, Pages 295-315

  Andrews, Janet I ^a   Diekema, Daniel J ^a   Yankowitz, Jerome ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; HERPES ZOSTER IMMUNOGLOBULIN; PYRIMETHAMINE SULFADIAZINE; SPIRAMYCIN; VALACICLOVIR;

CHICKENPOX; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE TRANSMISSION; HERPES; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INTRAUTERINE INFECTION; MATERNAL DISEASE; PARVOVIRUS; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0038786934     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-2712(03)00028-3     Document Type: Review

References (88)

1. Montoya JG, Remington JS. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, vol. 2. Philadelphia: Churchill Livingstone; 2000. p. 2858-88.
2. Sever JL, Ellenberg JH, Ley AC, Madden DL, Fuccillo DA, Tzan NR, et al. Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics 1988;82(2):181-92.
3. Duff P. Maternal and perinatal infection. In: Gabbe SG, Niebyl JR, Simpson JL, editors. Obstetrics: normal and problem pregnancies. 4th edition. Philadelphia: Churchill Livingstone; 2002. p. 1293-345.
4. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;180 (2 Pt 1):410-5.
5. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. 5th edition. Philadelphia: WB Saunders; 2001. p. 205-346.
6. Hohlfeld P. Fetal toxoplasmosis:ultrasonographic signs. Ultrasound Obstet Gynecol 1991;1:241-4.
7. Wilson M, Remington JS, Clavet C, Varney G, Press C, Ware D. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol 1997;35(12):3112-5.
8. Dannemann BR, Vaughan WC, Thulliez P, Remington JS. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 1990;28(9):1928-33.
9. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001;183(8):1248-53.
10. Jenum PA, Stray-Pedersen B, Gundersen AG. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. J Clin Microbiol 1997;35(8):1972-7.
11. Rossi CL. A simple, rapid enzyme-linked immunosorbent assay for evaluating immunoglobin G antibody avidity in toxoplasmosis. Diagn Microbiol Infect Dis 1998;30(1):25-30.
12. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331(11):695-9.
13. Romand S, Wallon M, Franck J, Thulliez P, Peyron F, Dumon H. Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis. Obstet Gynecol 2001;97(2):296-300.
14. Mombro M, Perathoner C, Leone A, Nicocia M, Moiraghi Ruggenini A, Zotti C, et al. Congenital toxoplasmosis: 10-year follow up. Eur J Pediatr 1995;154(8):635-9.
15. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316(4):183-6.
16. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D, et al. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318(5):271-5.
17. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262(5130):114-7.
18. Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999;281(12):1099-105.
19. Koch WC, Adler SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989;8(2):83-7.
20. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987;6(8):711-8.
21. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ 1990;300(6733):1166-70.
22. Pattison JR. Human parvovirus B19. BMJ 1994;308(6922):149-50.
23. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1(8426):419-21.
24. Blacklock HA, Mortimer PP. Aplastic crisis and other effects of the human parvovirus infection. Clin Haematol 1984;13(3):679-91.
25. Jordan JA. Diagnosing human parvovirus B19 infection: guidelines for test selection. Mol Diagn 2001;6(4):307-12.
26. Tiessen RG, van Elsacker-Niele AM, Vermeij-Keers C, Oepkes D, van Roosmalen J, Gorsira MC. A fetus with a parvovirus B19 infection and congenital anomalies. Prenat Diagn 1994;14(3):173-6.
27. Katz VL, McCoy MC, Kuller JA, Hansen WF. An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases. Am J Perinatol 1996;13(1):43-5.
28. Rodis JF, Quinn DL, Gary GW Jr, Anderson LJ, Rosengren S, Cartter ML, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990;163(4 Pt 1):1168-71.
29. Leads from the MMWR. Risks associated with human parvovirus B19 infection. JAMA 1989;261(10):1406-8.
30. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998;105(2):174-8.
31. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B 19 during pregnancy: a review. Obstet Gynecol Surv 1997;52(4):254-9.
32. Rodis JF, Borgida AF, Wilson M, Egan JF, Leo MV, Odibo AO, et al. Management of parvovirus infection in pregnancy and outcomes of hydrops: a survey of members of the Society of Perinatal Obstetricians. Am J Obstet Gynecol 1998;179(4):985-8.
33. Anderson MJ, Higgins PG, Davis LR, Willman JS, Jones SE, Kidd IM, et al. Experimental parvoviral infection in humans. J Infect Dis 1985;152(2):257-65.
34. American College of Obstetrics and Gynecologists practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000 [replaces educational bulletin number 177, February 1993]. Int J Gynaecol Obstet 2002;76(1):95-107.
35. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34(3):603-8.
36. Dieck D, Schild RL, Hansmann M, Eis-Hubinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 1999;19(12):1119-23.
37. Dong ZW, Zhou SY, Li Y, Liu RM. Detection of a human parvovirus intrauterine infection with the polymerase chain reaction. J Reprod Med 2000;45(5):410-2.
38. Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 2002;67(2):275-81.
39. Torok TJ, Wang QY, Gary GW Jr, Yang CF, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992;14(1):149-55.
40. Gurtler L. Difficulties and strategies of HIV diagnosis. Lancet 1996;348(9021):176-9.
41. Droste TM. IOM recommends routine HIV tests in pregnancy. Lancet 1998;352(9136):1294.
42. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al, Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994;331(18):1173-80.
43. Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999;341(6):394-402.
44. Centers for Disease Control and Prevention, Revised recommendations for HIV screening of pregnant women. MMWR Morb Mortal Wkly Rep 2001;50(RR-19):63-85.
45. Human immunodeficiency virus screening. Joint statement of the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Pediatrics 1999;104(1 Pt 1):128.
46. Fernandez MI, Wilson TE, Ethier KA, Walter EB, Gay CL, Moore J. Acceptance of HIV testing during prenatal care. Perinatal Guidelines Evaluation Project. Public Health Rep 2000;115(5):460-8.
47. Hornberger LK, Lipshultz SE, Easley KA, Colan SD, Schwartz M, Kaplan S, et al. Cardiac structure and function in fetuses of mothers infected with HIV: the prospective PCHIV multicenter study. Am Heart J 2000;140(4):575-84.
48. Balano K, Beckerman K, Ng V. Rapid HIV screening during labor. JAMA 1998;280(19):1664.
49. Stetler HC, Granade TC, Nunez CA, Meza R, Terrell S, Amador L, et al. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997;11(3):369-75.
50. American College of Obstetrics and Gynecologists practice bulletin. Perinatal viral and parasitic infections. Number 20, September 2000. Int J Gynaecol Obstet 2002;76(1):95-107.
51. Preblud SR, Orenstein WA, Bart KJ. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 1984;3(6):505-9.
52. McGregor JA, Mark S, Crawford GP, Levin MJ. Varicella zoster antibody testing in the care of pregnant women exposed to varicella. Am J Obstet Gynecol 1987;157(2):281-4.
53. Pastuszak AL, Levy M, Schick B, Zuber C, Feldkamp M, Gladstone J, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994;330(13):901-5.
54. Enders G, Miller E, Cradock-Watson J, Bolley I, Ridehalgh M. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994;343(8912):1548-51.
55. Pretorius DH, Hayward I, Jones KL, Stamm E. Sonographic evaluation of pregnancies with maternal varicella infection. J Ultrasound Med 1992;11(9):459-63.
56. Mouly F, Mirlesse V, Meritet JF, Rozenberg F, Poissonier MH, Lebon P, et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997;177(4):894-8.
57. Sauerbrei A, Muller D, Eichhorn U, Wutzler P. Detection of varicella-zoster virus in congenital varicella syndrome: a case report. Obstet Gynecol 1996;88(4 Pt 2):687-9.
58. Leads from the MMWR. Varicella-zoster immune globulin for the prevention of chickenpox. JAMA 1984;251(11):1401-9.
59. Brown ZA, Benedetti J, Ashley R, Burchctt S, Selke S, Berry S, et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991;324(18):1247-52.
60. Corey L. Herpes simplex virus. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, vol. 2. 5th edition. Philadelphia: Churchill Livingstone; 2000. p. 1564-80.
61. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 1999;341(19):1432-8.
62. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995;333(12):770-5.
63. Nahmias AJ, Dowdle WR, Josey WE, Naib ZM, Painter LM, Luce C. Newborn infection with herpesvirus hominis types 1 and 2. J Pediatr 1969;75(6):1194-203.
64. Hutto C, Arvin A, Jacobs R, Steele R, Stagno S, Lyrene R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987;110(1):97-101.
65. Baldwin S, Whitley RJ. Intrauterine herpes simplex virus infection. Teratology 1989;39(1):1-10.
66. Gray PH, Tudehope DI, Masel J. Cystic encephalomalacia and intrauterine herpes simplex virus infection. Pediatr Radiol 1992;22(7):529-32.
67. Centers for Disease Control and Prevention. 2002 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 2002;51(RR-6):1-84.
68. Moseley RC, Corey L, Benjamin D, Winter C, Remington ML. Comparison of viral isolation, direct immunofluorescence, and indirect immunoperoxidase techniques for detection of genital herpes simplex virus infection. J Clin Microbiol 1981;13(5):913-8.
69. Hardy DA, Arvin AM, Yasukawa LL, Bronzan RN, Lewinsohn DM, Hensleigh PA, et al. Use of polymerase chain reaction for successful identification of asymptomatic genital infection with herpes simplex virus in pregnant women at delivery. J Infect Dis 1990;162(5):1031-5.
70. Boggess KA, Watts DH, Hobson AC, Ashley RL, Brown ZA, Corey L. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Am J Obstet Gynecol 1997;176(2):443-51.
71. Lanouette JM, Duquette DA, Jacques SM, Qureshi F, Johnson MP, Berry SM. Prenatal diagnosis of fetal herpes simplex infection. Fetal Diagn Ther 1996;11(6):414-6.
72. Hoppen T, Eis-Hubinger AM, Schild RL, Enders G, Hansmann M, Rister M, et al. [Intrauterine herpes simplex virus infection.] Klin Padiatr 2001;213(2):63-8.
73. Scott LL, Sanchez PJ, Jackson GL, Zeray F, Wendel GD Jr. Acyclovir suppression to prevent cesarean delivery after first-episode genital herpes. Obstet Gynecol 1996;87(1):69-73.
74. Fowler KB, McCollister FP, Dahle AJ, Boppana S, Britt WJ, Pass RF. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130(4):624-30.
75. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995;171(5):1115-21.
76. Yow MD, Williamson DW, Leeds LJ, Thompson P, Woodward RM, Walmus BF, et al. Epidemiologic characteristics of cytomegalovirus infection in mothers and their infants. Am J Obstet Gynecol 1988;158(5):1189-95.
77. Boppana SB, Rivera LB, Fowler KB, Mach M, Britt WJ. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344(18):1366-71.
78. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999;104(1 Pt 1):55-60.
79. Azam AZ, Vial Y, Fawer CL, Zufferey J, Hohlfeld P. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001;97(3):443-8.
80. Chandler SH, Alexander ER, Holmes KK. Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis 1985;152(2):249-56.
81. Pass R. Cytomegalovirus. In: Fields BN, Knipe DM, Howley PM, Griffin DE, editors. Fields' virology. 4th edition. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2675-705.
82. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000;137(1):90-5.
83. Guerra B, Lazzarotto T, Quarta S, Lanari M, Bovicelli L, Nicolosi A, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000;183(2):476-82.
84. Lipitz S, Yagel S, Shalev E, Achiron R, Mashiach S, Schiff E. Prenatal diagnosis of fetal primary cytomegalovirus infection. Obstet Gynecol 1997;89(5 Pt 1):763-7.
85. Lazzarotto T, Guerra B, Spezzacatena P, Varani S, Gabrielli L, Pradelli P, et al. Prenatal diagnosis of congenital cytomegalovirus infection. J Clin Microbiol 1998;36(12):3540-4.
86. Donner C, Liesnard C, Brancart F, Rodesch F. Accuracy of amniotic fluid testing before 21 weeks' gestation in prenatal diagnosis of congenital cytomegalovirus infection. Prenat Diagn 1994;14(11):1055-9.
87. Liesnard C, Donner C, Brancart F, Gosselin F, Delforge ML, Rodesch F. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000;95(6 Pt 1):881-8.
88. Lamy ME, Mulongo KN, Gadisseux JF, Lyon G, Gaudy V, Van Lierde M. Prenatal diagnosis of fetal cytomegalovirus infection. Am J Obstet Gynecol 1992;166(1 Pt 1):91-4.